Table 3 Unadjusted associations for composite outcome of survival without receiving ECMO among infants with CDH.
Variable(s) | Died or Received ECMO | Survived w/o ECMO | OR 95% CI | p |
|---|---|---|---|---|
N (%) | 1334 | 2305 | ||
Gestational age at birth < 35 weeks | 168 (12.6) | 231 (10) | 0.77 (0.63, 0.95) | 0.017 |
Female Sex (N, %) | 597 (44.8) | 886 (38.4) | 0.77 (0.67, 0.88) | <0.001 |
SGA < 10th centile (n, %) | 212 (15.9) | 238 (10.3) | 0.61 (0.5, 0.74) | <0.001 |
5 min Apgar < 3 (n, %) | 119 (8.9) | 53 (2.3) | 0.24 (0.17, 0.33) | <0.001 |
Any BSI (n, %) | 192 (14.4) | 152 (6.6) | 0.42(0.34, 0.53) | <0.001 |
Birth Year | <0.001 | |||
2010–2013 | 366 (27.4) | 470 (20.4) | referent | . |
2014–2016 | 327 (24.5) | 482 (20.9) | 1.15 (0.94, 1.4) | 0.168 |
2017–2019 | 336 (25.2) | 691 (30) | 1.6 (1.33, 1.93) | <0.001 |
2020–2023 | 305 (22.9) | 662 (28.7) | 1.69 (1.39, 2.05) | <0.001 |
Antenatal diagnosis (n, %) | 1076 (80.7) | 1464 (63.5) | 0.42 (0.36, 0.49) | <0.001 |
Pre-repair pneumothorax (n, %) | 179 (13.4) | 54 (2.3) | 0.15 (0.11, 0.21) | <0.001 |
Congenital heart disease (CHD) | ||||
ASD/VSD | 245 (18.4) | 347 (15.1) | 0.73 (0.61, 0.88) | 0.001 |
Other CHD | 110 (8.2) | 63 (2.7) | 0.3 (0.22, 0.41) | <0.001 |
None | 979 (73.4) | 1895 (82.2) | referent | - |
ASD (n, %) | 126 (9.4) | 221 (9.6) | 1.02 (0.81, 1.28) | 0.888 |
VSD (n, %) | 153 (11.5) | 183 (7.9) | 0.67 (0.53, 0.83) | <0.001 |
Either ASD OR VSD or AVSD (n, %) | 247 (18.5) | 347 (15.1) | 0.78 (0.65, 0.93) | 0.070 |
Lowest pH in first 12 h after admission | 7.1 [7,7.3] | 7.3 [7.2,7.4] | - | |
<7.0 | 282 (21.1) | 64 (2.8) | referent | - |
7.0–7.19 | 467 (35) | 402 (17.4) | 3.79 (2.8, 5.13) | <0.001 |
7.2–7.29 | 269 (20.2) | 589 (25.6) | 9.65 (7.1, 13.12) | <0.001 |
7.3–7.45 | 184 (13.8) | 886 (38.4) | 21.22 (15.49, 29.05) | <0.001 |
>7.45+ | 24 (1.8) | 86 (3.7) | 15.79 (9.32, 26.76) | <0.001 |
Thoracic liver position (n, %) | 862 (64.6) | 918 (39.8) | 0.36 (0.32, 0.42) | <0.001 |
Median age at referral (days, 25–75th %ile) | 1 [1,1] | 1 [1,2] | 1.2(1.1, 1.3) | 0.001 |
Median maximum PCO2 in first 12 h after referral (25–75th %ile) | 68.3 [52, 90] | 49 [40.8,61] | - | |
PCO2 < 60 mmHg | 467 (35) | 1455 (63.1) | 4.12 (3.54, 4.79) | <0.001 |
ECMO (n, %) | 950 (71.2) | 0 (0, 3.273474E153) | 0.920 | |
Left-sided CDH | 985 (73.8) | 1761 (76.4) | 1.27 (1.07, 1.5) | 0.006 |
Primary CDH repair (n, %) | 164 (12.3) | 1184 (51.4) | 5.46 (4.51, 6.61) | <0.001 |
Median birthweight (g, 25–75th %ile) | 2915 [2500, 3270] | 3080 [2676, 3440] | 1(1,1.1) | <0.001 |
Race/ethnicity (n, %) | ||||
non-Hispanic White | 697 (52.2) | 1272 (55.2) | referent | <0.001 |
non-Hispanic Black | 233 (17.5) | 222 (9.6) | 0.52 (0.43, 0.64) | <0.001 |
non-Hispanic Other | 100 (7.5) | 204 (8.9) | 1.12 (0.86, 1.44) | 0.395 |
Hispanic ethnicity | 237 (17.8) | 474 (20.6) | 1.1 (0.91, 1.31) | 0.322 |
Post-natal drug withdrawal (n, %) | 219 (16.4) | 294 (12.8) | 0.74 (0.62, 0.9) | 0.002 |
Neurologic diagnoses (n, %) | 139 (10.4) | 61 (2.6) | 0.23 (0.17, 0.32) | <0.001 |
Genetic/chromosomal diagnoses (n, %) | 85 (6.4) | 85 (3.7) | 0.56 (0.41, 0.77) | <0.001 |
Kidney Failure (n, %) | 179 (13.4) | 31 (1.3) | 0.09 (0.06, 0.13) | <0.001 |
Congenital pulmonary abnormalities (non-CDH), (n, %) | 22 (1.6) | 14 (0.6) | 0.36 (0.19, 0.71) | 0.003 |
Airway Malacia (n, %) | 71 (5.3) | 79 (3.4) | 0.63 (0.45, 0.88) | 0.006 |
Gastrointestinal Disorders (n, %) | 102 (7.6) | 166 (7.2) | 0.94 (0.73, 1.21) | 0.618 |